Back to GetFilings.com



Table of Contents

FORM 10-Q

 


 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

(MARK ONE)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2005

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number 1-10765

 


 

UNIVERSAL HEALTH SERVICES, INC.

(Exact name of registrant as specified in its charter)

 


 

DELAWARE   23-2077891

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

UNIVERSAL CORPORATE CENTER

367 SOUTH GULPH ROAD

KING OF PRUSSIA, PENNSYLVANIA 19406

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code (610) 768-3300

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. Common shares outstanding, as of April 30, 2005:

 

    Class A     3,328,404    
    Class B   54,400,787    
    Class C        335,800    
    Class D          27,096    

 



Table of Contents

UNIVERSAL HEALTH SERVICES, INC.

 

INDEX

 

     PAGE NO.

PART I. FINANCIAL INFORMATION

    

Item 1. Financial Statements

    

Condensed Consolidated Statements of Income - Three Months Ended March 31, 2005 and 2004

   3

Condensed Consolidated Balance Sheets – March 31, 2005 and December 31, 2004

   4

Condensed Consolidated Statements of Cash Flows Three Months Ended March 31, 2005 and 2004

   5

Notes to Condensed Consolidated Financial Statements

   6 through 16

Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition

   17 through 30

PART II. Other Information

   31 through 33

Signatures

   34

 

Page 2 of 34 Pages


Table of Contents

 

PART I. FINANCIAL INFORMATION

 

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(amounts in thousands, except per share amounts)

(unaudited)

 

     Three Month Ended
March 31,


     2005

   2004

Net revenues

   $ 1,090,981    $ 982,576

Operating charges:

             

Salaries, wages and benefits

     438,232      399,914

Other operating expenses

     248,816      221,111

Supplies expense

     149,327      135,858

Provision for doubtful accounts

     82,455      83,596

Depreciation and amortization

     43,609      36,454

Lease and rental expense

     17,503      17,405
    

  

       979,942      894,338
    

  

Income before interest expense, minority interests and income taxes

     111,039      88,238

Interest expense, net

     11,995      10,902

Minority interests in earnings of consolidated entities

     9,556      4,941
    

  

Income before income taxes

     89,488      72,395

Provision for income taxes

     33,086      26,813
    

  

Income from continuing operations

     56,402      45,582

Income from discontinued operations, net of income tax expense of $2,870 and $350 during the three month periods ended March 31, 2005 and 2004, respectively

     5,007      601
    

  

Net income

   $ 61,409    $ 46,183
    

  

Basic earnings per share:

             

From continuing operations

   $ 0.98    $ 0.79

From discontinued operations

     0.09      0.01
    

  

Total basic earnings per share

   $ 1.07    $ 0.80
    

  

Diluted earnings per share:

             

From continuing operations

   $ 0.91    $ 0.73

From discontinued operations

     0.08      0.01
    

  

Total diluted earnings per share

   $ 0.99    $ 0.74
    

  

Weighted average number of common shares - basic

     57,523      57,564

Add: Shares for conversion of convertible debentures

     6,577      6,577

Other share equivalents

     316      946
    

  

Weighted average number of common shares and equivalents - diluted

     64,416      65,087
    

  

 

See accompanying notes to these condensed consolidated financial statements.

 

Page 3 of 34 Pages


Table of Contents

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollar amounts in thousands, unaudited)

 

     March 31,
2005


    December 31,
2004


 
Assets                 

Current assets:

                

Cash and cash equivalents

   $ 54,188     $ 33,125  

Accounts receivable, net

     624,181       552,538  

Supplies

     61,503       60,729  

Other current assets

     36,039       29,663  

Assets of facilities held for sale

     1,058       132,870  
    


 


Total current assets

     776,969       808,925  
    


 


Property and equipment

     2,310,052       2,267,284  

Less: accumulated depreciation

     (853,353 )     (819,218 )
    


 


       1,456,699       1,448,066  

Other assets:

                

Goodwill

     619,404       619,064  

Deferred charges

     13,350       14,416  

Other

     117,345       132,372  
    


 


       750,099       765,852  
    


 


     $ 2,983,767     $ 3,022,843  
    


 


Liabilities and Stockholders’ Equity                 

Current liabilities:

                

Current maturities of long-term debt

   $ 16,113     $ 16,968  

Accounts payable and accrued liabilities

     463,027       419,116  

Federal and state taxes

     51,963       22,456  

Liabilities of facilities held for sale

     222       11,116  
    


 


Total current liabilities

     531,325       469,656  
    


 


Other noncurrent liabilities

     251,352       243,617  

Minority interests

     190,863       186,543  

Long-term debt

     684,397       852,229  

Deferred income taxes

     50,935       50,212  

Commitments and contingencies

                

Common stockholders’ equity:

                

Class A Common Stock, 3,328,404 shares outstanding in 2005 and 3,328,404 in 2004

     33       33  

Class B Common Stock, 54,379,071 shares outstanding in 2005 and 54,058,695 in 2004

     544       541  

Class C Common Stock, 335,800 shares outstanding in 2005 and 335,800 in 2004

     3       3  

Class D Common Stock, 27,096 shares outstanding in 2005 and 27,401 in 2004

     —         —    

Capital in excess of par, net of deferred compensation of $16,418 in 2005 and $1,659 in 2004

     21,912       21,231  

Cumulative dividends

     (27,917 )     (23,272 )

Retained earnings

     1,281,595       1,220,186  

Accumulated other comprehensive (loss) income

     (1,275 )     1,864  
    


 


       1,274,895       1,220,586  
    


 


     $ 2,983,767     $ 3,022,843  
    


 


 

See accompanying notes to these condensed consolidated financial statements.

 

Page 4 of 34 Pages


Table of Contents

 

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(amounts in thousands, unaudited)

 

    

Three Months Ended

March 31,


 
     2005

    2004

 

Cash Flows from Operating Activities:

                

Net income

   $ 61,409     $ 46,183  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation & amortization

     45,506       40,706  

Accretion of discount on convertible debentures

     3,428       3,291  

Gains on sales of assets and businesses

     (9,095 )     —    

Provision for asset impairment

     3,105       —    

Changes in assets & liabilities, net of effects from acquisitions and dispositions:

                

Accounts receivable

     (65,960 )     (71,645 )

Accrued interest

     4,147       4,510  

Accrued and deferred income taxes

     32,084       25,667  

Other working capital accounts

     25,197       16,310  

Other assets and deferred charges

     15,451       7,310  

Other

     3,733       5,035  

Minority interest in earnings of consolidated entities, net of distributions

     5,293       5,279  

Accrued insurance expense, net of commercial premiums paid

     21,862       19,024  

Payments made in settlement of self-insurance claims

     (11,548 )     (6,544 )
    


 


Net cash provided by operating activities

     134,612       95,126  
    


 


Cash Flows from Investing Activities:

                

Property and equipment additions, net of disposals

     (57,920 )     (70,436 )

Proceeds received from sales of assets and businesses

     124,589       425  

Acquisition of businesses

     (5,225 )     (37,665 )
    


 


Net cash provided by (used in) investing activities

     61,444       (107,676 )
    


 


Cash Flows from Financing Activities:

                

Additional borrowings

     8,114       19,637  

Reduction of long-term debt

     (176,799 )     —    

Issuance of common stock

     771       1,431  

Repurchase of common shares

     (1,255 )     (350 )

Dividends paid

     (4,645 )     (4,650 )

Financing costs on new revolving credit facility

     (1,179 )     —    
    


 


Net cash (used in) provided by financing activities

     (174,993 )     16,068  
    


 


Increase in cash and cash equivalents

     21,063       3,518  

Cash and cash equivalents, beginning of period

     33,125       34,863  
    


 


Cash and cash equivalents, end of period

   $ 54,188     $ 38,381  
    


 


Supplemental Disclosures of Cash Flow Information:

                

Interest paid

   $ 4,422     $ 3,187  
    


 


Income taxes paid, net of refunds

   $ 4,272     $ 1,498  
    


 


 

See accompanying notes to these condensed consolidated financial statements.

 

Page 5 of 34 Pages


Table of Contents

 

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(1) General

 

This Report on Form 10-Q is for the Quarterly period ended March 31, 2005. In this Quarterly Report, “we,” “us,” “our” and the “Company” refer to Universal Health Services, Inc. and its subsidiaries.

 

You should carefully review the information contained in this Quarterly Report, and should particularly consider any risk factors that we set forth in this Quarterly Report and in other reports or documents that we file from time to time with the SEC. In this Quarterly Report, we state our beliefs of future events and of our future financial performance. In some cases, you can identify those so-called “forward-looking statements” by words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. You should be aware that those statements are only our predictions. Actual events or results may differ materially. In evaluating those statements, you should specifically consider various factors, including the risks outlined in Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition – Forward Looking Statements and Risk Factors. Those factors may cause our actual results to differ materially from any of our forward-looking statements.

 

The condensed consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships controlled by us, or our subsidiaries, as managing general partner. The condensed consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission and reflect all normal and recurring adjustments which, in our opinion, are necessary to fairly present results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements, significant accounting policies and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2004. Certain prior year amounts have been reclassified to conform with current year financial statement presentation.

 

(2) Relationship with Universal Health Realty Income Trust and Related Party Transactions

 

Relationship with Universal Health Realty Income Trust:

 

At March 31, 2005, we held approximately 6.7% of the outstanding shares of Universal Health Realty Income Trust (the “Trust”). We serve as Advisor to the Trust under an annually renewable advisory agreement pursuant to the terms of which, we conduct the Trust’s day-to-day affairs, provide administrative services and present investment opportunities. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying condensed consolidated statements of income, of $355,000 and $374,000 during the three month periods ended March 31, 2005 and 2004, respectively. Our pre-tax share of income from the Trust was $300,000 and $342,000 during the three month periods ended March 31, 2005 and 2004, respectively, and is included in net revenues in the accompanying condensed consolidated statements of income. The carrying value of this investment was $9.2 million at March 31, 2005 and $9.5 million at December 31, 2004, and is included in other assets in the accompanying balance sheets. The market value of this investment was $22.2 million at March 31, 2005 and $25.2 million at December 31, 2004.

 

As of March 31, 2005, we leased five hospital facilities from the Trust with terms expiring in 2006 through 2009. On December 31, 2004 we completed the purchase of the real estate assets of the Virtue Street Pavilion located in Chalmette, Louisiana, from the Trust. Total rent expense under the operating leases on hospital facilities with the Trust was $4.1 million for the three months ended March 31, 2005 (combined expense for five facilities) and $4.5 million during three months ended March 31, 2004 (combined expense for six

 

Page 6 of 34 Pages


Table of Contents

facilities). Pursuant to the leases on four of these hospital facilities we have five, five-year renewal options and we have four, five-year renewal options on the remaining hospital facility lease. Also pursuant to these leases with the Trust, we have an option to purchase the respective leased facilities at the end of the lease terms or any renewal terms. In addition, we have rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by limited liability companies in which the Trust holds non-controlling ownership interests.

 

Other Related Party Transactions:

 

In connection with a long-term incentive compensation plan that was terminated during the third quarter of 2002, as of March 31, 2005, we had $1.1 million of gross loans outstanding to various employees (including $237,000 million to officers) which have been charged to compensation expense to date and are scheduled to be forgiven during the second quarter of 2005. As of December 31, 2004, we had $1.7 million of gross loans outstanding to various employees (including $688,000 million to officers) which had been charged to compensation expense at that date.

 

Our Chairman and Chief Executive Officer is a member of the Board of Directors of Broadlane, Inc. In addition, the Company and certain Directors and members of our executive management team own approximately 6% of the outstanding shares of Broadlane, Inc. as of March 31, 2005. Broadlane, Inc. provides contracting and other supply chain services to us and various other healthcare organizations.

 

A member of our Board of Directors and member of the Executive Committee is Of Counsel to the law firm used by us as our principal outside counsel. This Board member is also the trustee of certain trusts for the benefit of the Chief Executive Officer and his family. This law firm also provides personal legal services to our Ch